Activist Shareholder Demands Accountability from Equus Board
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 57 minutes ago
0mins
Source: Newsfilter
- Shareholder Challenge Initiated: An activist shareholder owning 5.61% of Equus Total Return, Inc. has filed a Schedule 13D with the SEC, calling for immediate board accountability and a strategic review, marking the first public challenge to the management's stewardship in fifteen years.
- Significant Decline in Net Asset Value: As of December 31, 2025, Equus's net asset value per share fell to $1.19, down 66.5% from $3.55 at the end of 2023, with total net asset value plummeting from $48.2 million to $16.6 million, indicating severe value erosion over the past two years.
- Ongoing Investment Losses: The company reported a net investment loss of $3.7 million in 2025, marking its fifth consecutive year of losses, with operating expenses reaching $5.1 million, leaving only $133,000 in cash available, highlighting a critical liquidity crisis.
- Inappropriate Executive Compensation: Despite no dividends being paid and a significant drop in net asset value, the three named executives received a total of $1,872,271 in compensation in 2025, which represents about 22% of the company's market capitalization of $8.6 million, raising serious concerns about the governance structure.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy EQS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on EQS
About EQS
Equus Total Return, Inc. (the Fund) is a closed-end management investment company. The Fund's investment objective is to maximize the total return to the Company's stockholders in the form of current investment income and long-term capital gains by investing in the debt and equity securities of small and middle market capitalization companies that are generally not publicly traded at the time of its investment. It seeks to invest in companies pursuing growth through acquisition or organically, leveraged buyouts, management buyouts and recapitalizations of existing businesses or special situations. The Fund's income-producing investments includes debt securities, including subordinate debt, debt convertible into common or preferred stock, or debt combined with warrants and common and preferred stock. It invests in the portfolio company, Equus Energy, LLC, which makes investments in companies in the energy sector, with particular emphasis on income-producing oil and gas properties.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Shareholder Challenge: Activist Howard Todd Horberg, holding 5.61% of shares, filed Schedule 13D with the SEC, marking the first public challenge to Equus's board management and calling for a strategic review ahead of the June 30 annual meeting, indicating strong dissatisfaction with corporate governance.
- Severe Investment Losses: Since the current CEO took control in 2011, Equus has reported five consecutive years of net investment losses, with net asset value plummeting to $1.19 per share in 2025, down 65% from approximately $48.2 million total net assets in 2023, highlighting significant failures in shareholder value creation.
- Executive Compensation Controversy: Despite no dividends and a sharp decline in net asset value, the total compensation for three executives reached $1,872,271 in 2025, accounting for 22% of the company's market cap, provoking strong shareholder dissent regarding the management's compensation structure and indicating governance failure.
- Independent Directors' Lack of Accountability: The independent directors of Equus hold less than 0.5% of shares, resulting in a lack of meaningful influence over company decisions, leading to governance imbalances; Horberg calls for an independent financial advisor to reassess the company's long-term strategy.
See More
- Shareholder Challenge Initiated: An activist shareholder owning 5.61% of Equus Total Return, Inc. has filed a Schedule 13D with the SEC, calling for immediate board accountability and a strategic review, marking the first public challenge to the management's stewardship in fifteen years.
- Significant Decline in Net Asset Value: As of December 31, 2025, Equus's net asset value per share fell to $1.19, down 66.5% from $3.55 at the end of 2023, with total net asset value plummeting from $48.2 million to $16.6 million, indicating severe value erosion over the past two years.
- Ongoing Investment Losses: The company reported a net investment loss of $3.7 million in 2025, marking its fifth consecutive year of losses, with operating expenses reaching $5.1 million, leaving only $133,000 in cash available, highlighting a critical liquidity crisis.
- Inappropriate Executive Compensation: Despite no dividends being paid and a significant drop in net asset value, the three named executives received a total of $1,872,271 in compensation in 2025, which represents about 22% of the company's market capitalization of $8.6 million, raising serious concerns about the governance structure.
See More
- Net Asset Growth: As of March 31, 2026, Equus Total Return reported net assets of $20.9 million, reflecting a significant increase from the previous quarter, indicating effective asset management strategies.
- Increase in NAV per Share: The net asset value per share rose from $1.19 on December 31, 2025, to $1.50, marking a 26% increase, which demonstrates the company's positive progress in enhancing shareholder value.
- Stock Performance: Following the announcement, Equus Total Return's shares increased by 5.49%, indicating a positive market reaction to its financial performance, which may attract more investor interest.
- Historical Earnings Data: The disclosure of historical earnings data provides investors with a comprehensive financial background, enhancing market confidence in the company's future growth potential.
See More
- Net Asset Growth: As of March 31, 2026, Equus reported net assets of $20.9 million, up from $16.57 million as of December 31, 2025, indicating positive asset management performance that enhances investor confidence.
- Increase in Net Asset Value per Share: The net asset value per share rose from $1.19 on December 31, 2025, to $1.50, reflecting improved asset value and potentially attracting more investor interest in the company's stock performance.
- Appreciation in Morgan E&P Holdings: Due to significantly higher crude oil prices, the value of Equus's stake in Morgan E&P increased by $5 million, showcasing the investment return potential in the energy sector and strengthening the overall stability of its asset portfolio.
- Decline in CitroTech Holdings: Despite CitroTech's share price rising from $8.08 to $8.63, Equus's total valuation of its holdings in the company decreased from $6.8 million to $6.3 million, indicating a need for improved risk management in diversified investments.
See More
- Net Asset Decline: As of December 31, 2025, Equus reported net assets of $16.6 million, a significant drop from $26.5 million as of September 30, 2025, indicating financial pressure and market challenges faced by the company.
- Decrease in Net Asset Value per Share: The net asset value per share fell from $1.90 on September 30, 2025, to $1.19, reflecting a substantial decline in asset management and investment returns, which may impact investor confidence.
- Morgan E&P Value Loss: Due to a lower oil price outlook and production limitations, Equus's investment in Morgan E&P decreased by $12.35 million, highlighting the company's exposure to risks in energy investments and its negative impact on overall financial health.
- CitroTech Investment Appreciation: Equus's holdings in CitroTech, including a convertible note and stock, increased in value from $5.2 million to $6.8 million, indicating some success in diversification that may support future financial recovery.
See More
- Acquisition of Erevo: Equasens has acquired an 80% controlling stake in Erevo, expected to generate €7.4 million in revenue by 2025, significantly enhancing its market position in healthcare professional training.
- Training Product Expansion: This acquisition integrates Erevo's online courses with Equasens' existing services, improving training quality and addressing the healthcare industry's demand for continuous education, which is anticipated to boost customer satisfaction and market share.
- Synergies Realized: Erevo's digital training solutions complement Equasens' hardware and software offerings, expected to create substantial operational and marketing synergies that support the company's growth in the rapidly evolving healthcare education market.
- Future Development Potential: By leveraging Erevo's expertise, Equasens plans to develop new AI-driven features to enhance educational effectiveness, ensuring its leadership position in the healthcare training sector.
See More








